Welcome to our dedicated page for Community Health Sys SEC filings (Ticker: CYH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Community Health Systems, Inc. (NYSE: CYH) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Community Health Systems is a large operator in the general medical and surgical hospitals industry, with affiliates that own or lease hospitals and operate more than 1,000 sites of care across 36 distinct markets in 14 states. Its filings offer detailed information about hospital operations, financing activities, strategic transactions and governance matters.
Investors can review Current Reports on Form 8-K that describe material events such as offerings of senior secured notes, tender offers and redemptions of existing notes, and entries into or completions of significant purchase agreements. Recent 8-K filings outline the issuance of 9.750% Senior Secured Notes due 2034, the tender offer for 5.625% Senior Secured Notes due 2027, and subsequent redemptions, as well as the completion of asset sales and divestitures of ownership interests in hospitals and related businesses.
The filings also cover acquisition and disposition transactions, including significant dispositions that require unaudited pro forma condensed consolidated financial statements. These documents explain how the sale of hospital ownership interests or ambulatory outreach laboratory assets affects the company’s reported financials. Item 2.01 disclosures and related exhibits provide the underlying purchase agreements and pro forma information.
Governance and executive changes are documented in Item 5.02 sections of Form 8-K, where Community Health Systems reports appointments of its Chief Executive Officer, Chief Financial Officer and Chief Accounting Officer, as well as retirement and consulting arrangements for former executives. These filings describe role transitions, responsibilities and, in some cases, compensation arrangements.
On Stock Titan, CYH filings are updated as new documents are posted to EDGAR, and AI-powered tools summarize key points from lengthy filings. Users can quickly identify major financing actions, divestitures, leadership changes and other material events without reading every page of the underlying documents, while still having direct access to the full SEC filings for deeper review.
Community Health Systems, Inc. announced a series of leadership appointments. Kevin J. Hammons, previously President and Interim Chief Executive Officer, has been appointed Chief Executive Officer and also joins the Board of Directors, with his board term running until the 2026 Annual Meeting of Stockholders. As a management director, he will not receive additional board compensation.
Jason K. Johnson, formerly Senior Vice President, Chief Accounting Officer and Interim Chief Financial Officer, has been appointed Executive Vice President and Chief Financial Officer and will continue as Chief Accounting Officer until January 1, 2026. Effective that date, Phillip A. Posey, currently Vice President, Accounting and Financial Reporting, will become Senior Vice President and Chief Accounting Officer and the company’s principal accounting officer. All three executives were already serving in key roles, and there are no new specific compensation arrangements disclosed in connection with these appointments.
Community Health Systems (CYH) insider plans additional stock sale. A Form 144 notice reports a planned sale of 66,666 shares of common stock through UBS Financial Services Inc. on or about 12/09/2025, with an indicated aggregate market value of 225,664 and 138,519,615 shares of common stock outstanding. The shares to be sold were acquired on 12/05/2025 via a stock option exercise paid in cash.
The filing also lists prior sales by Tim Hingtgen over the past three months. These include 519,645 common shares sold on 10/28/2025 for gross proceeds of 2,152,243 and 13,168 common shares sold on 10/29/2025 for gross proceeds of 55,971. The signer represents that they are not aware of undisclosed material adverse information about the company’s current or prospective operations.
Community Health Systems, Inc. completed a significant asset sale of its ambulatory outreach business across 13 states. On December 1, 2025, its wholly owned subsidiary, CHS/Community Health Systems, Inc., closed an asset purchase agreement with Laboratory Corporation of America Holdings, under which the buyer acquired select assets and assumed certain leases related to patient service centers and in-office phlebotomy locations.
The company received approximately $194 million in cash, before transaction expenses, as the purchase price. Because this transaction is considered a significant disposition, Community Health Systems is providing unaudited pro forma condensed consolidated financial statements, including pro forma income statements for the nine months ended September 30, 2025 and the year ended December 31, 2024, and a pro forma balance sheet as of September 30, 2025.
Community Health Systems, Inc. (CYH) received an amended Schedule 13G/A (Amendment No. 2) from a large group of Apollo-affiliated investment entities. The filing reports that Apollo Capital Management, L.P., Apollo Capital Management GP, LLC, Apollo Management Holdings, L.P., and Apollo Management Holdings GP, LLC each beneficially own 13,171,818 shares of CYH common stock, representing 9.5% of the outstanding shares based on 138,519,615 shares outstanding as of October 17, 2025.
The ownership is held through numerous Apollo funds and managed vehicles, including credit, absolute return and specialty funds, all listed as “Reporting Persons.” Each reporting entity has shared voting and dispositive power over its respective shares and no sole voting or dispositive power. The Apollo entities and certain executives formally disclaim beneficial ownership of the reported shares beyond their indirect roles, and certify that the securities were not acquired to change or influence control of Community Health Systems, consistent with a passive investment filing under Schedule 13G.
CastleKnight/Weitman group filed an amended Schedule 13G reporting a passive stake in Community Health Systems (CYH). The filing shows beneficial ownership of 12,262,508 shares of Class A common stock, representing 8.8% of the class as of 09/30/2025.
The reporting persons report shared voting and dispositive power over 12,262,508 shares and no sole voting or dispositive power. They certify the securities were not acquired and are not held for the purpose of changing or influencing control.
Community Health Systems (CYH) entered a material definitive agreement to sell its 80% interests in two Clarksville, Tennessee joint ventures (including Tennova Healthcare - Clarksville) to Vanderbilt University Medical Center and its subsidiaries. The purchase price is $600 million, payable at closing and subject to adjustments for closing net working capital and amounts due to the joint ventures from CHS.
The buyer already holds minority stakes and will acquire the remaining interests through this transaction. Closing is expected in early 2026, subject to regulatory approvals and other closing conditions. Either party may terminate if the deal is not consummated by December 31, 2026. At closing, the parties plan to enter into transition services agreements for information technology and operational support.
A press release announcing the agreement was issued the same day and filed as an exhibit. The agreement includes customary representations, warranties, covenants, and indemnification provisions.
Community Health Systems (CYH) affiliate filed a Form 144 notice to sell 532,813 shares of common stock on the NYSE, with an aggregate market value of $2,226,625. The proposed sales are listed through UBS Financial Services Inc. with an approximate sale date of October 28, 2025.
Shares outstanding were 138,519,615; this is a baseline figure, not the amount being sold. The filing lists prior acquisition of the securities primarily via RSU and PSU grants from the issuer across 2013–2023.
Community Health Systems (CYH) reported a return to profitability in Q3 2025. Net operating revenues were $3,087 million, essentially flat year over year. Income from operations was $243 million versus a loss of $205 million a year ago. Net income attributable to stockholders was $130 million, or $0.96 diluted EPS, compared with a loss of $391 million, or $(2.95) diluted EPS.
For the nine months, revenues were $9,379 million and net income attributable to stockholders was $399 million, or $2.97 diluted EPS, versus a loss of $446 million, or $(3.38) diluted EPS, last year. Results reflect a net gain of approximately $242 million from divestitures year to date and a Q3 income tax benefit of about $163 million tied to federal legislation. Interest expense was $216 million in Q3.
Cash from operations reached $277 million year to date. Asset sales provided $1,012 million of proceeds. Long‑term debt declined to $10,589 million from $11,432 million at year‑end, supported by refinancing, including $700 million of 10.75% senior secured notes due 2033 and $1.790 billion of 9.75% senior secured notes due 2034, alongside tenders/redemptions of 2027 and 2028 notes.
Community Health Systems (CYH) furnished an update via an 8-K announcing operating results for the third quarter ended September 30, 2025. The company also provided updated 2025 annual earnings guidance in a press release attached as Exhibit 99.1.
The guidance reflects the company’s historical operating performance, current trends and other assumptions outlined in the press release on pages 16–20. The information in this report (including the exhibit) is deemed furnished, not filed.
Community Health Systems, Inc. reported that its wholly owned subsidiary CHSPSC, LLC entered into a consultancy agreement with retiring Chief Executive Officer Tim L. Hingtgen. Effective after his retirement as director and executive officer on September 30, 2025, Mr. Hingtgen will serve as a consultant from October 1, 2025 through September 30, 2026, advising the management team on healthcare operations, strategy, and other assignments as requested by Interim Chief Executive Officer Kevin J. Hammons or his designee. Under the agreement, Mr. Hingtgen will receive consulting fees of $33,333.33 per month and will be subject to restrictions on competition, solicitation, and conflicts of interest with CHSPSC, LLC or its affiliates. The full consulting agreement is filed as Exhibit 10.1.